ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2071

Chronic Widespread Pain Versus Multi-Site Pain: Does the Distribution Matter?

Marcus Beasley and Gary J. Macfarlane, Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Chronic pain, Diagnostic criteria, Epidemiologic methods, fibromyalgia and pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes: Research Focus

Session Type: Abstract Submissions (ACR)

Background/Purpose: The ACR 1990 diagnostic criteria for fibromyalgia includes a definition for chronic widespread pain (CWP) that depends on a particular distribution of pain sites. The new proposed ACR 2010 criteria instead has a Widespread Pain Index which takes into account the number of sites only. The purpose of this analysis was to see, amongst persons reporting multi-site pain, if the distribution of pain sites has any association with a number of potential risk markers after adjustment for the number of sites.

Methods: The MUSICIAN survey was a general population survey aimed at identifying people with CWP for an intervention study. A questionnaire was sent by post to adults registered at family doctors in two areas of the United Kingdom. Questions included age, gender, employment status, smoking behaviour, height, weight, and questions on pain included a manikin in 35 sections to indicate the location of the pain. Respondents were included in the analysis who indicated that they had between 3 and 16 areas of pain, and that the pain had lasted 3 months or more. (People with less than 3 sites could not meet the ACR 1990 definition of widespread pain, while most of those with more than 16 sites did). Participants were classed as having pain that was widespread or not according to the ACR 1990 criterion. A number of potential associations with having widespread pain were tested using logistic regression to provide odds ratios (OR) with 95% confidence intervals (CI). These models were then adjusted for number of pain sites to see if any associations with the distribution pattern remained after accounting for having pain in multiple areas.

Results:  14680 people responded to the questionnaire, of which 7536 reported some chronic pain (prevalence 51.3%). In those with chronic pain, the median number of pain sites was 5 (interquartile range 3 to 9), and the prevalence of pain that met the ACR 1990 criterion for being widespread was 32.1%. Included in the analysis were 5715 respondents with chronic pain in 3 to 16 areas, of which 2037 (35.6%) met the criterion for widespread pain. Gender age, smoking and employment status all had significant associations with ACR 1990 widespread pain (see table). After adjustment for number of pain sites most of these associations either became non-significant or were attenuated.

Conclusion: We have shown that when number of pain sites was taken into account, the particular distribution of sites did not continue to have significant relationships with many associated factors. This might indicate that is not so much that the pattern of pain locations that is important as the multiplicity of areas. This may have implications in conditions such as fibromyalgia where pain across multiple areas is involved. Based on this data, the use of a measure that looks at the number of pain sites rather than a particular distribution is acceptable as a diagnostic criterion.

Not widespread

Widespread

Unadjusted

Adj for no. of sites

Number

Percentage

Number

Percentage

OR

95% CI

OR

95% CI

Gender

Male

1600

68.0%

754

32.0%

1

1

Female

2078

61.8%

1283

38.2%

1.31

1.17-1.46

1.13

0.98-1.30

Age

Under 40

495

61.0%

317

39.0%

1

1

40-49

647

63.6%

370

36.4%

0.89

0.74-1.08

0.90

0.71-1.14

50-59

821

65.8%

426

34.2%

0.81

0.67-0.97

0.81

0.65-1.02

60-69

822

63.3%

476

36.7%

0.90

0.75-1.08

0.85

0.68-1.07

Over 70

893

66.6%

448

33.4%

0.78

0.65-0.94

0.77

0.62-0.97

Smoking

Never smoked

1951

65.7%

1019

34.3%

1

1

Ex-smoker

1198

64.6%

657

35.4%

1.05

0.93-1.19

0.87

0.74-1.01

Current smoker

466

58.6%

329

41.4%

1.35

1.15-1.59

1.09

0.89-1.33

Employment

Full-time

1369

66.3%

696

33.7%

1

1

Part-time

533

66.8%

265

33.2%

0.98

0.82-1.16

0.84

0.67-1.04

Retired

1272

65.3%

677

34.7%

1.05

0.92-1.19

0.85

0.71-0.996

Unable to work

169

49.1%

175

50.9%

2.04

1.62-2.56

0.77

0.56-1.04

Student

26

54.2%

22

45.8%

1.66

0.94-2.96

1.32

0.64-2.73

Unemployed

34

53.1%

30

46.9%

1.74

1.05-2.86

1.42

0.74-2.71

Other

229

61.1%

146

38.9%

1.25

0.9996-1.57

0.93

0.70-1.24

BMI

Under 20

163

59.9%

109

40.1%

1.20

0.94-1.57

1.10

0.80-1.52

20-25

1291

64.5%

711

35.5%

1

1

25-30

1388

66.1%

713

33.9%

0.93

0.82-1.06

0.82

0.70-0.97

30-35

494

62.9%

291

37.1%

1.07

0.90-1.27

0.93

0.75-1.16

35 and over

342

61.6%

213

38.4%

1.13

0.93-1.37

0.83

0.65-1.07

 


Disclosure:

M. Beasley,
None;

G. J. Macfarlane,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/chronic-widespread-pain-versus-multi-site-pain-does-the-distribution-matter/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology